Genetesis Lands Strategic Investment to Close Series B

Published on
May 8, 2020
Contributors
Tech Ohio
The Voice of Ohio Third Frontier

Genetesis Inc, a medical technology company that has developed non-invasive, biomagnetic CardioFluxTM imaging, today announced several important updates. The company has closed significant strategic investments from TDK Ventures and an undisclosed Fortune 500 global, healthcare company, completing a $9.2M Series B financing. The round included participation by return investors CincyTech, Ohio Innovation Fund and Mark Cuban.